| Not Yet Recruiting | Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC) Primary Sclerosing Cholangitis | Phase 3 | 2025-03-01 |
| Recruiting | Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease Celiac Disease | Phase 2 | 2024-06-10 |
| Completed | Mesalazine Oral Suspension in Active Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 2 | 2023-02-09 |
| Completed | Different Doses of Naronapride vs. Placebo in Gastroparesis Gastroparesis | Phase 2 | 2023-01-03 |
| Completed | Different Doses of ZED1227 vs. Placebo in NAFLD NAFLD, Liver Fibrosis | Phase 2 | 2022-04-19 |
| Recruiting | Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE Eosinophilic Esophagitis | Phase 3 | 2021-05-21 |
| Unknown | Norursodeoxycholic Acid vs. Placebo in NASH Nonalcoholic Steatohepatitis | Phase 2 | 2019-07-08 |
| Active Not Recruiting | norUrsodeoxycholic Acid vs Placebo in PSC Primary Sclerosing Cholangitis | Phase 3 | 2018-02-08 |
| Completed | Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 3 | 2016-01-15 |
| Completed | Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 3 | 2015-11-11 |
| Completed | Budesonide 9 mg Capsules in Active UC Colitis, Ulcerative | Phase 2 | 2015-10-01 |
| Completed | Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PRO Ulcerative Colitis | Phase 3 | 2014-10-01 |
| Terminated | Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2014-07-21 |
| Completed | Budesonide for Induction of Remission in Incomplete Microscopic Colitis Incomplete Microscopic Colitis | Phase 3 | 2014-05-01 |
| Completed | Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Procti Proctitis | Phase 2 | 2013-09-01 |
| Completed | Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverti Uncomplicated Diverticulitis | Phase 2 | 2013-08-01 |
| Completed | TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) Active Ulcerative Colitis | Phase 3 | 2013-01-01 |
| Completed | Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis Primary Sclerosing Cholangitis | Phase 2 | 2012-12-01 |
| Completed | Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 2 | 2011-06-01 |
| Completed | Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease Crohn´s Disease | Phase 2 | 2010-11-01 |
| Completed | Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea Traveler's Diarrhea | Phase 3 | 2010-11-01 |
| Completed | Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis Lymphocytic Colitis | Phase 3 | 2010-05-01 |
| Terminated | Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis Diverticulitis | Phase 3 | 2010-01-01 |
| Completed | 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease Crohn´s Disease | Phase 3 | 2009-11-01 |
| Completed | Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD) Oral Chronic Graft vs Host Disease | Phase 3 | 2009-03-01 |
| Terminated | Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) Primary Biliary Cirrhosis | Phase 3 | 2009-02-01 |
| Completed | Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis Primary Biliary Cirrhosis | Phase 4 | 2008-11-01 |
| Terminated | Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis Radiation Proctitis | Phase 2 | 2008-09-01 |
| Completed | SOIBD Collagenous Colitis Maintenance Study Induction and Maintaining Remission of Collagenous Colitis | Phase 3 | 2008-04-01 |
| Terminated | Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis Diverticulitis | Phase 3 | 2008-01-01 |
| Completed | Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) Colitis, Ulcerative | Phase 3 | 2007-10-01 |
| Completed | Pharmacokinetic Investigation of UDCA in Bile and Serum Healthy | Phase 1 | 2007-05-01 |
| Completed | Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis Collagenous Colitis | Phase 3 | 2007-03-01 |
| Completed | OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2005-07-01 |
| Completed | Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Colitis, Ulcerative, Recurrence | Phase 3 | 2005-05-01 |
| Completed | Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) Crohn's Disease | Phase 3 | 2004-09-01 |
| Completed | Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study Colonic Diverticulosis | Phase 2 | 2002-05-01 |
| Completed | Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine Crohn's Disease | Phase 3 | 2002-02-01 |
| Completed | Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis Autoimmune Hepatitis | Phase 2 / Phase 3 | 2001-03-01 |